Cytokine expression in circulating T lymphocytes from patients undergoing carotid endarterectomy

Journal of Cardiovascular Surgery

Volumn 44, Issue 2, 2003, Pages 237-242

  Profumo, E ^a   Siracusano, A ^a   Ortona, E ^a   Margutti, P ^a   Carra, A ^b   Costanzo, A ^b   Capoano, R ^b   Salvati, B ^b   Riganò, Rachele ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atherosclerosis; Carotid artery diseases; CD4 positive T lymphocytes; CD8 positive T lymphocytes; Cytokines

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD DONOR; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOKINE RELEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; MALE; PHENOTYPE; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

AGED; CAROTID ARTERY DISEASES; CYTOKINES; ENDARTERECTOMY, CAROTID; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MIDDLE AGED; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037588951     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ross, R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999;340:115-26.
2. Van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
3. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997;17:1859-67.
4. Vink A, Schoneveld AH, Richard W, de Kleijn DP, Falk E, Borst C et al. Plaque burden, arterial remodeling and plaque vulnerability: determined by systemic factors? J Am Coll Cardiol 2001;38:718-23.
5. Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 2000;86:3J-8.
6. Hansson GK, Libby P. The role of the lymphocytes. in: Fuster V, Topol EJ, editors. Atherosclerosis and coronary artery disease. Philadelphia PA: Lippincott-Raven; 1996.
7. + and CD8+ lymphocytes. Eur J Immunol 1995;25:644-8.
8. + T cells in atopic asthma. J Allergy Clin Immunol 1997;100:373-8.
9. Croft M, Carter L, Swain SL, Dutton SW. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 1994;180:1715-28.
10. Gupta S, Pablo AM, Jiang X,Wang N, Tall AR, Schindler C. IFN-γ potentiates atherosclerosis in apoE knock-out mice. J Clin Invest 1997;99:2752-61.
11. Treska V, Topolcan O, Pecen L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med 2000;38:1161-4.
12. Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 2001;88:877-87.
13. George J, Shoenfeld Y, Gilburd B, Afek A, Shaish A, Harats D. Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 of Mycobacterium tuberculosis. Circ Res 2000;86:1203-10.
14. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of proinflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 1999;145:33-43.
15. Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani LE. Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. J Thromb Thrombolysis 2000;9:217-22.
16. Mazzone A, De Servi S, Vezzoli M, Fossati G, Mazzucchelli I, Gritti D et al. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic hearth disease. Atherosclerosis 1999;145:369-74.
17. Schall TJO, Hehir RE, Goedell D, Lamb JR. Uncoupling of cytokine mRNA expression and protein secretion during the induction phase of T cell anergy. J Immunol 1992;148:381-7.
18. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R et al. Interleukin-4, -5, and -6 and TNF-α in normal and asthmatic airways: evidence for the human mast cells as an important source of these cytokines. Am J Respir Cell Mol Biol 1994;10:471-80.
19. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. Immunol Meth 1993;159:197-207.
20. +CD27-lymphocyte subpopulation. J Immunol 1995;154:4294-301.
21. Assenmacher M, Schmitz J, Radbruch A. Flow cytometric determination of cytokines in activated murine helper lymphocytes: expression of interleukin-10 and interferon-γ and interleukin-4 producing cells. Eur J Immunol 1994;24:1097-101.
22. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995;86:1408-19.
23. Maino VC, Picker LJ. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry 1998;34:207-15.
24. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler Thromb Vasc Biol 1995;15:1512-31.
25. Harris TB, Ferrucci L, Tracy LP, Corti MC, Wacholder S, Ettinger WH jr et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-12.
26. Fowkes FG, Lowe GD, Housley E, Rattray A, Rumley A, Elton RA et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993;342:8863-6.
27. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;351:88-92.
28. Belch JJ. The relationship between white blood cells and arterial disease. Curr Opin Lipidol 1994;5:440-6.
29. Sharrett AR, Sorlie PD, Chambless LE, Folsom AR, Hutchinson RG, Heiss G et al. Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999;149:843-52.
30. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
31. Lee TS, Yen HC, Pan CC, Chau LY. The role of interleukin 12 in the development of atherosclerosis in apoE-deficient mice. Arterioscler Thromb Vasc Biol 1999;19:734-42.
32. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;2:1598-603.
33. Zwacka RM, Zhou W, Zhang Y, Darby CJ, Dudus L, Halldorson J et al. Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP-1 and NF-kB activation. Nat Med 1998;4:698-704.